These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 1936074)
1. Absolute bioavailability of moxonidine. Theodor R; Weimann HJ; Weber W; Michaelis K Eur J Drug Metab Pharmacokinet; 1991; 16(2):153-9. PubMed ID: 1936074 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics/bioavailability of colchicine in healthy male volunteers. Achtert G; Scherrmann JM; Christen MO Eur J Drug Metab Pharmacokinet; 1989; 14(4):317-22. PubMed ID: 2633927 [TBL] [Abstract][Full Text] [Related]
3. Influence of food on the oral bioavailability of moxonidine. Theodor RA; Weimann HJ; Weber W; Müller M; Michaelis K Eur J Drug Metab Pharmacokinet; 1992; 17(1):61-6. PubMed ID: 1499598 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of moxonidine after single and repeated daily doses in healthy volunteers. Trenk D; Wagner F; Jähnchen E; Plänitz V J Clin Pharmacol; 1987 Dec; 27(12):988-93. PubMed ID: 3437071 [TBL] [Abstract][Full Text] [Related]
5. Steady state investigation of possible pharmacokinetic interactions of moxonidine and glibenclamide. Müller M; Weimann HJ; Eden G; Weber W; Michaelis K; Dilger C; Achtert G Eur J Drug Metab Pharmacokinet; 1993; 18(3):277-83. PubMed ID: 8149947 [TBL] [Abstract][Full Text] [Related]
6. Metabolism and disposition of moxonidine in Fischer 344 rats. He MM; Abraham TL; Lindsay TJ; Chay SH; Czeskis BA; Shipley LA Drug Metab Dispos; 2000 Apr; 28(4):446-59. PubMed ID: 10725314 [TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamic action and pharmacokinetics of moxonidine after single oral administration in hypertension patients. Kirch W; Hutt HJ; Plänitz V J Clin Pharmacol; 1990 Dec; 30(12):1088-95. PubMed ID: 2273081 [TBL] [Abstract][Full Text] [Related]
8. Metabolism and disposition of the antihypertensive agent moxonidine in humans. He MM; Abraham TL; Lindsay TJ; Schaefer HC; Pouliquen IJ; Payne C; Czeskis B; Shipley LA; Oliver SD; Mitchell MI Drug Metab Dispos; 2003 Mar; 31(3):334-42. PubMed ID: 12584161 [TBL] [Abstract][Full Text] [Related]
9. Absolute bioavailability of intranasal fluticasone furoate in healthy subjects. Allen A; Down G; Newland A; Reynard K; Rousell V; Salmon E; Scott R Clin Ther; 2007 Jul; 29(7):1415-20. PubMed ID: 17825692 [TBL] [Abstract][Full Text] [Related]
10. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions. Chen C; Bujanover S; Kareht S; Rapoport AM Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369 [TBL] [Abstract][Full Text] [Related]
11. Determination of moxonidine (BDF 5895) in plasma by gas chromatography-negative ion chemical ionization mass spectrometry. Rudolph M; Janssen W; Strassner M J Pharm Biomed Anal; 1992 May; 10(5):323-8. PubMed ID: 1511033 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and urinary excretion of eprosartan in Chinese healthy volunteers of different gender. Xu HR; Chen WL; Li XN; Liu GY; Chu NN; Yu C Pharmazie; 2007 Oct; 62(10):782-4. PubMed ID: 18236785 [TBL] [Abstract][Full Text] [Related]
13. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions. Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490 [TBL] [Abstract][Full Text] [Related]
14. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study. Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325 [TBL] [Abstract][Full Text] [Related]
15. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects. Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095 [TBL] [Abstract][Full Text] [Related]
16. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent. Prichard BN; Owens CW; Graham BR J Hum Hypertens; 1997 Aug; 11 Suppl 1():S29-45. PubMed ID: 9321737 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and bioequivalence study of a generic amlodipine tablet formulation in healthy male volunteers. Sailer R; Arnold P; Erenmemişoğlu A; Martin W; Tamur U; Kanzik I; Hincal AA Arzneimittelforschung; 2007; 57(7):462-6. PubMed ID: 17803059 [TBL] [Abstract][Full Text] [Related]
18. Bioequivalence study of generic tablet formulations containing ethinylestradiol and chlormadinone acetate in healthy female volunteers. Bonn M; Eydeler U; Barkworth M; Rovati LC Arzneimittelforschung; 2009; 59(12):651-8. PubMed ID: 20108652 [TBL] [Abstract][Full Text] [Related]
19. Bioavailability and pharmacokinetics of ketanserin in elderly subjects. Kurowski M Eur J Clin Pharmacol; 1985; 28(4):411-7. PubMed ID: 3161741 [TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics and pharmacokinetics of pinacidil after a single dose of a new slow release tablet in healthy volunteers. Bareggi SR; Gambaro V; Valenti M; Benvenuti C Arzneimittelforschung; 1998 Jul; 48(7):730-3. PubMed ID: 9706373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]